BSEResult9h ago · 14 Aug 2026, 07:48 pm

Unaudited Financial Results for the quarter ended 30.06.2026

Ortin Global Ltd · 539287

✦ AI SummaryResults

Ortin Global Ltd has announced unaudited financial results for the quarter ended 30.06.2026, with a net loss of Rs. -33.79 crores and EPS of -0.42. The company's revenue and expenses are presented in the attached statement.

Analysis Scores

Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment3/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Ortin Global Ltd - 539287 - Unaudited Financial Results For The Quarter Ended 30.06.2026

Attachments (1)

📄

0a64d0d3-412c-470b-81da-4ea746343e51.pdf

pdf

Download →
View document text
ORTIN GLOBAL LIMITED (Formerly Known as ORTIN LABORATORIES LIMITED) CIN: L68200TG1986PLC006885 To Date: 14.08.2026 1. BSE Limited, 2. National Stock Exchange of India Limited, P.J. Towers, Dalal Street, Exchange Plaza, Bandra- Kurla Complex, Mumbai-400001 Mumbai 400051 Scrip Code: 539287 Symbol: ORTINGLOBE Dear Sir/Madam, Sub: Outcome of Board Meeting held on 14.08.2026 Ref: Company’s Letter dated 07.08.2026 Unit: Ortin Global Limited (formerly known as Ortin Laboratories Limited) With reference to the subject cited, this is to inform the Exchanges that at the meeting of the Board of Directors of Ortin Global Limited held on Friday, 14.08.2026 at 05:30 p.m. at the Registered Office of the Company at D. No. 1-8-305, Ground Floor, Chikkadpally, Musheerabad (Delivery), Hyderabad- 500020, Telangana, the following items were inter-alia considered and approved: 1. Un-Audited financial results for the quarter ended 30.06.2026. (Enclosed) 2. Limited Review Report for the quarter ended 30.06.2026. (Enclosed) The meeting concluded at 07:35 p.m. Thanking you. Yours sincerely, For Ortin Global Limited (formerly known as Ortin Laboratories Limited) S. Murali Krishna Murthy Managing Director (DIN:00540632) Regd. Office: D. No. 1-8-305, Ground Floor, Chikkadpally, Musheerabad (Delivery), Hyderabad-500020, Telangana, India. Email:info@ortinlabsindia.com Website:www.ortinlabsindia.com Ph. No. +91 9052011118 ORTIN GLOBAL LIMITED (Formerly known as ORTIN LABORATORIES LIMITED) STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30.06.2026 Quarter Ended Year Ended Particulars 30.06.2026 31.03.2026 30.06.2025 31.03.2026 31.03.25 S No Un Audited Audited Un Audited Audited Audited 1 a) Net Sales / Income from Operations 1.16 3.44 3.98 10.05 34.22 2 b) Other Operating Income 0.44 27.34 4.11 31.45 4.13 3 Total Income (1+2) 1.60 30.78 8.09 41.50 38.35 4 Expenditure a) Cost of Material Consumed 1.04 2.97 3.64 7.67 18.42 b) Employee Benefits Expenses 4.02 2.97 3.55 15.53 15.34 c) Changes in inventory 0.00 0.56 1.02 1.98 3.04 d) Finance cost 0.00 0.12 0.04 0.22 0.27 e) Depreciation 0.03 0.03 0.00 0.05 1.17 f) Other Expenditure 29.97 25.02 16.13 88.39 85.78 Total Expenses 35.06 31.67 24.38 113.84 124.02 Profit / (Loss) before Exceptional Items -85.67 5 and tax (3-4) -33.46 -0.89 -16.29 -72.34 6 Exceptional Items 0.00 0.00 0.00 0.00 -1.92 7 Profit / (Loss) before tax (5-6) -33.46 -0.89 -16.29 -72.34 -83.75 8 Tax Expense a) Current Tax 0.00 0.00 0.00 0.00 0.00 b) Deferred Tax 0.33 0.04 1.25 1.70 0.89 Profit / (Loss) after tax for the period 9 from continuing operations (7-8) -33.79 -0.93 -17.54 -74.04 -84.64 10 Other comprehensive income (i) Items that will not be reclassified to profit or loss 0.00 0.00 0.00 0.00 0.00 (ii) Tax on items that will not be reclassified to profit or loss 0.00 0.00 0.00 0.00 0.00 (i) Items that will be reclassified to profit or loss 0.00 0.00 0.00 0.00 0.00 (ii) Income tax relating to items that will be reclassified to Profit or Loss 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Total comprehensive income for the period (comprising Profit(Loss) and other comprehensive income for the 11 period (9+10) -33.79 -0.93 -17.54 -74.04 -84.64 12 Paid-up equity share capital 813.14 813.14 813.14 813.14 813.14 (Face value of Rs. 10/- per share ) 13 Other Equity ( 689.43) ( 615.39) 14 Earinings Per Share (EPS) a) Basic and diluted EPS before extraordinary items for the period, for the year to date and for the previous year (not to be annualised) -0.42 -0.01 -0.22 -0.91 -1.04 b) Basic and diluted EPS after Extraordinary items for the period, for the year to date and for the previous year (not to be annualised) -0.42 -0.01 -0.22 -0.91 -1.04 Notes: (i)TheaboveresultshavebeenrecommendedbytheAuditCommitteeandapprovedbytheBoardofDirectorsattheirmeeting held on 14.08.2026. (ii)ThefinancialresultsofthecompanyhavebeenpreparedinaccordancewithIndianAccountingStandards(IndAS)notified undertheCompanies(IndianAccountingStandards)Rules.2015asamendedbytheCompanies(IndianAccountingStandards) (Amendment) Rules 2016. (iii) The figures for the quarter ended June 30, 2026 are balancing figures between the audited figures in respect of the full financial year and year to date figures upto the first quarter for the respective period which is subject to limited review. (iv) Previous period figures have been regrouped / rearranged wherever necessary, to make them comparable. (v) The entire operations of the Company relate to only one segment hence segmental reporting as per Ind AS 108 is not applicable. (vi) The Statutory Auditors of the Company have carried out "Limited Review" of the above unaudited financial results and their Report has been placed before the Board at the said Meeting as required under Regulation 33 of SEBI (LODR) Regulations, 2015. (vii) The results are also available on the website of the Company www.ortinlabsindia.com. Place: Hyderabad For and on Behalf of the Board of Directors Date: 14.08.2026 ORTIN GLOBAL LIMITED S.MURALI KRISHNA MURTHY Managing Director DIN: 00540632 A MATHESH & RAMANA INDIA CHARTERED ACCOUNTANTS Independent Auditor's Limited Review Report on unaudited quarterly and year to date financial results of the Company To The Board of Directors of Ortin Global Limited (Formerly known as Ortin Laboratories Limited) 1. We have reviewed the accompanying statement of Unaudited Financial Results of Ortin Global Limited (Formerly known as Ortin Laboratories Limited) ("the Cormpany") for the quarter ended on 30 June, 2026 ("the statement"). This statement is the responsibility of the Company's Management and has been approved by the Company's Board of Directors. Our responsibility is to issue a report on these financial statements based on our review. 2. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 “Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. 3. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with applicable accounting standards and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement. Our conclusion on the Statement is not modified in respect of the above matters. For MATHESH& RAMANA CHARTERED ACCOUNTANTS KMHESHA RA FRN: 002020s HYDERABAD B. V. RAMAXA REDDY RED AC M. No: 026967 |Partner Place: Hyderabad Date: 14.08.2026 UDIN: 26026967HCEZPL1035 E-mail: mateshca@yahoo.co.in #3-6-145, Himayatnagar, Hyderabad - 5000 29. Ph: 2.322 1822|2 322 6993 / 2322 2863